Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007005987) METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/005987 International Application No.: PCT/US2006/026250
Publication Date: 11.01.2007 International Filing Date: 06.07.2006
IPC:
C12Q 1/68 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
Applicants:
APPLERA CORPORATION [US/US]; c/o Celera Genomics 45 West Gude Drive, C1-1 #316 Rockville, MD 20850, US (AllExceptUS)
LEE, Candy [GB/US]; US (UsOnly)
BIRSE, Charles, E. [GB/US]; US (UsOnly)
KIM, Yeounjin [KR/US]; US (UsOnly)
Inventors:
LEE, Candy; US
BIRSE, Charles, E.; US
KIM, Yeounjin; US
Agent:
SUN-HOFFMAN, Lin; c/o Celera Genomics 45 West Gude Drive, C1-1 #316 Rockville, MD 20850, US
Priority Data:
60/696,50406.07.2005US
Title (EN) METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1
(FR) PROCEDES ET COMPOSITIONS POUR TRAITER DES MALADIES AYANT POUR CIBLE MABA1
Abstract:
(EN) Methods and compositions for diagnosing, detecting and treating a colon disease associated with differential expression of MABAl in comparison to healthy cells. Also provided are antagonists or agonists of MABAl, and methods for screening agents that modulate the MABAl level or activity in vivo or in vitro.
(FR) L'invention concerne des procédés et des compositions pour diagnostiquer, détecter, et traiter une colopathie associée à une expression différentielle de MABA1 par rapport à des cellules saines. L'invention concerne également des antagonistes ou des agonistes de MABA1, ainsi que des procédés pour cribler des agents qui modulent le niveau ou l'activité de MABA1 in vivo ou in vitro.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)